Patients Take Center Stage at EHA 2026

Modern hematology treatment must not only focus on evidence of clinical outcomes. As patients with malignant hematologic diseases live longer, their experiences and quality of life should increasingly be incorporated into both research and clinical practice. This is also reflected in the new EHA recommendations for Hemoglobinopathies.